Bioactive Lipids and Their Derivatives in Biomedical Applications
Open Access
- 1 September 2021
- journal article
- review article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 29 (5), 465-482
- https://doi.org/10.4062/biomolther.2021.107
Abstract
Lipids, which along with carbohydrates and proteins are among the most important nutrients for the living organism, have a variety of biological functions that can be applied widely in biomedicine. A fatty acid, the most fundamental biological lipid, may be classified by length of its aliphatic chain, and the short-, medium-, and long-chain fatty acids and each have distinct biological activities with therapeutic relevance. For example, short-chain fatty acids have immune regulatory activities and could be useful against autoimmune disease; medium-chain fatty acids generate ketogenic metabolites and may be used to control seizure; and some metabolites oxidized from long-chain fatty acids could be used to treat metabolic disorders. Glycerolipids play important roles in pathological environments, such as those of cancers or metabolic disorders, and thus are regarded as a potential therapeutic target. Phospholipids represent the main building unit of the plasma membrane of cells, and play key roles in cellular signaling. Due to their physical properties, glycerophospholipids are frequently used as pharmaceutical ingredients, in addition to being potential novel drug targets for treating disease. Sphingolipids, which comprise another component of the plasma membrane, have their own distinct biological functions and have been investigated in nanotechnological applications such as drug delivery systems. Saccharolipids, which are derived from bacteria, have endotoxin effects that stimulate the immune system. Chemically modified saccharolipids might be useful for cancer immunotherapy or as vaccine adjuvants. This review will address the important biological function of several key lipids and offer critical insights into their potential therapeutic applications.Keywords
Funding Information
- Ministry of Science and ICT, Republic of Korea (NRF-2021R1A2B5B03002123, NRF-2018R1A5A2024425)
This publication has 162 references indexed in Scilit:
- Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistanceScientific Reports, 2013
- Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Metabolic Control of Vesicular Glutamate Transport and ReleaseNeuron, 2010
- Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumorsThe FASEB Journal, 2010
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvantProceedings of the National Academy of Sciences of the United States of America, 2010
- Spinal glial TLR4‐mediated nociception and production of prostaglandin E2 and TNFBritish Journal of Pharmacology, 2010
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Membrane lipids: where they are and how they behaveNature Reviews Molecular Cell Biology, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008